Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Novel treatment strategy for glaucoma and ocular hypertension claimed by Allergan

March 15, 2007

Financing at Potentia to support AMD program

March 9, 2007

TG-100801 completes first phase I study for macular degeneration

March 2, 2007

Merck Frosst and Nippon Soda patents disclose new agents for treating eye disorders

March 2, 2007

Treatment begins in pivotal program for LX-211 in uveitis

Feb. 22, 2007

Inspire to commercialize AzaSite in U.S. and Canada

Feb. 20, 2007

AzaSite Plus well tolerated in phase I study

Feb. 15, 2007

Once-daily Xibrom formulation effective in treating postoperative ocular pain

Feb. 13, 2007

Thymosin beta 4 modulates NF-kB inflammatory signaling in corneal epithelium

Feb. 13, 2007

New therapeutic agents for glaucoma disclosed in recent Aerie patent

Feb. 8, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...